Structural Heart

This structural heart channel includes news, videos, podcasts and other content related to diagnosis and treatment of structural heart disease. Topics covered include heart valve repair and replacement, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and closing holes in the heart using, including occlusion of atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent foramen ovales (PFOs).

The U.S. Food and Drug Administration (FDA) announced that Abiomed is recalling the Instructions for Use for its Impella Left Sided Blood Pumps because the pump catheter may perforate (cut) the wall of the left ventricle in the heart.
News | FDA
FDA Announces Abiomed Recall of the Instructions for Use for the Impella Left Sided Blood Pumps due to Perforation Risks

March 21, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abiomed is recalling the Instructions for ...

Home March 21, 2024
Home
Visual Thrombus Assessment as presented by Dr. William Gray at the Cardiovascular Research Technologies (CRT) 2024 conference.
News | Left Atrial Appendage (LAA) Occluders
Conformal Medical's CLAAS System Demonstrates Low Thrombogenicity Compared to Commercially Available LAAO Devices

March 18, 2024 — Conformal Medical, Inc. announced that the CLAAS System was featured in a podium presentation at the Ca ...

Home March 18, 2024
Home
Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States
News | Structural Heart
New Late-breaking Data from Medtronic Evolut Low Risk Trial Demonstrate Strong Clinical and Cost-effectiveness Benefits of TAVR Platform

March 12, 2024 — Medtronic plc, a global leader in healthcare technology, today announced two late-breaking data ...

Home March 12, 2024
Home
A look at DAIC's top-viewed content for February 2024
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
A Look at February's Top 10

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being ...

Home March 05, 2024
Home
The academic medical centers earned distinguished three-star ratings from The Society of Thoracic Surgeons (STS) for their patient care and outcomes in adult cardiac surgery
News | Cardiovascular Surgery
Hackensack Meridian Hackensack University and Jersey Shore University Medical Centers Again Ranked Among the Elite Hospitals in North America for Open Heart Surgery

February 26, 2024 — Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center ...

Home February 26, 2024
Home
The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first transcatheter aortic valve replacement (TAVR) in 2002
Feature | Cardiovascular Surgery
In Memoriam: Alain Cribier, MD, FACC, TAVR Pioneer

The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first transca ...

Home February 23, 2024
Home
On March 25, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI."
News | Cardiac Imaging
Webinar on Optimizing Structural Heart Workflows to be Rescheduled

PLEASE NOTE: This webinar has been postponed to a later date. 


A new date will be posted in the coming days. 


 

...

Home February 29, 2024
Home
First of its kind artificial heart valve now approved by FDA for treatment of tricuspid regurgitation.
News | Cardiovascular Clinical Studies
Henry Ford Health Heart Failure Patient First in Michigan to Receive Breakthrough Device

February 21, 2024 — An 80-year-old woman from Frankenmuth, Michigan is the first Henry Ford Health structural heart ...

Home February 21, 2024
Home
The Medtronic APOLLO Clinical Trial is evaluating the safety and efficacy of an investigative device called the Intrepid Transcatheter Mitral Valve Replacement System (TMVR) for moderate-to-severe or severe symptomatic mitral regurgitation (MR) in patients who may be unsuitable for approved transcatheter repair or surgery.
News | Structural Heart
Hackensack Meridian Jersey Shore University Medical Center Providing State-of-the-Art Medtronic APOLLO Clinical Trial Treating Heart Valve Disease

February 20, 2024 — As New Jersey’s leading provider of high-quality cardiac procedures and diagnostic testing and an ...

Home February 20, 2024
Home
Panel of independent experts reviewed data from the TRILUMINATE pivotal trial demonstrating safety, effectiveness and quality-of-life benefits of the TriClip system
News | Structural Heart
FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

February 15, 2024 — Abbott announced that the Circulatory System Devices Panel of the Medical Devices Advisory Committee ...

Home February 15, 2024
Home
Physicians in the Smidt Heart Institute at Cedars-Sinai have pioneered using a catheter-based approach to treat patients with tricuspid valve disease. Image by Getty.
News | Structural Heart
Smidt Heart Institute Physicians Advance Transcatheter Tricuspid Valve Replacement

February 9, 2024 — Physicians in the Smidt Heart Institute at Cedars-Sinai have achieved two significant firsts ...

Home February 09, 2024
Home
The EVOQUE system is indicated for the improvement of health status in patients with symptomatic severe TR despite optimal medical therapy (OMT), for whom tricuspid valve replacement is deemed appropriate by a heart team.
News | FDA
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy Earns FDA Approval for Tricuspid Valve

February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is ...

Home February 02, 2024
Home
Here is a look at the most-read content during the month of January on dicardiology.com
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: What Viewers Were Reading in January

It is a new year with lots of new content! Here is a look at the most-read content during the month of January on dicard ...

Home February 01, 2024
Home
Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under age 65 with severe aortic stenosis, many hospitals are still opting for a nonsurgical approach in patients under 60—possibly with poorer survival rates
News | Cardiovascular Surgery
Almost 50% of Patients Under 60 Years Choose TAVR Over Surgical Aortic Valve Replacement with Worse Outcomes

January 29, 2024 — Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under ...

Home January 29, 2024
Home
The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias-abnormal heartbeats that start in the heart’s two lower chambers-and an elevated risk of sudden cardiac death in patients with mitral valve disease
Feature
Spotlight on Advancements in Mitral Valve Repair, Research

You may not know Carol Barr, but in the future, she could save your life. 


Barr’s death at 39 from sudden cardiac ...

Home January 24, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now